Possible involvement of advanced glycation end-products in bone resorption

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 5, 1996, Pages 54-57

  Miyata, T ^a   Kawai, R ^b   Taketomi, S ^c   Sprague, S M ^d  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Advanced glycation end products; Bone resorption; Interleukin 1 ; Interleukin 6

Indexed keywords

AMYLOID; INTERLEUKIN 6; MATRIX PROTEIN; SUGAR; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ANIMAL TISSUE; BONE MATRIX; CALCIUM TRANSPORT; CASE REPORT; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONOCYTE; MOUSE; NEWBORN; NONHUMAN; OSTEOLYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SENESCENCE;

EID: 0030513684     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp5.54     Document Type: Conference Paper

References (21)

1. Horowitz MC. Cytokines and estrogen in bone: anti-osteoporotic effects. Science 1993; 260: 626-627
2. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1321
3. Miyata T, Oda O, Inagi R et al. β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243-1252
4. 2-microglobulin forming amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA in press
5. Koch KM. Dialysis-related amyloidosis. Kidney Int 1992; 41: 1416-1429
6. 2-microglobulin a mediator of bone disease? Kidney Int 1995; 47: 1-6
7. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin I. J Clin Invest 1994; 93: 521-528
8. 2-microglobulin modified with advanced glycation end products. Kidney Int 1996; 49: 538-550
9. Iida Y, Miyata T, Inagi R, Sugiyama S, Maeda K. β2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophys Res Commun 1994; 201: 1235-1241
10. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 1989; 264: 21597-21602
11. Girasole G, Jilika RL, Passeri G et al. β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992; 89: 883-891
12. Horowitz MC, Coleman DL, Flood PM, Kupper TS, Jilka RL. Parathyroid hormone and lipopolysaccharide induce murine osteoblast-like cells to secrete a cytokine indistinguishable from granulocyte-macrophage colony-stimulating factor. J Clin Invest 1989; 83: 149-157
13. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 1988; 240: 1546-1548
14. Neeper M, Schmidt AM, Brett J et al. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992; 267: 14998-15006
15. Schmidt AM, Yon SD, Brett J, Mora R, Nowygrod R, Stern D. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 1993; 91: 2155-2168
16. 2-microglobulin induces calcium efflux from cultured neonatal mouse calvariae. Am. J. Physiol. 1992; 263: F540-545
17. 2-microglobulin-induced bone mineral dissolution. Kidney Int 1995; 47: 587-591
18. Makita Z, Radoff S, Rayfield EJ et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1990; 325:836-842
19. Dyer DG, Dunn JA, Thorpe SR et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993; 91: 2463-2469
20. Odetti P, Forgarty J, Sell DR, Monnier VM. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992; 41: 153-159
21. Notoya K, Yoshida K, Taketomi S, Yamazaki I, Kumegawa M. Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells. Calcif Tissue Int 1993; 53: 206-209